Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05456100 · ClinicalTrials.gov registry record · NA

Chinese American Cancer Survivors Writing Study

A NA study of Cancer, sponsored by New York University.

Recruiting
Registry status
NA
Development phase
108
Enrollment target
1
Study location

NCT05456100 is a NA study of Cancer that is actively recruiting participants, run by New York University. The registered enrollment target is 108 participants, below the 3,491-participant average among 615 other Cancer trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05456100, a NA study of Cancer, is actively recruiting participants, sponsored by New York University.

RECRUITING
Registry status
NA
Development phase
108 participants
Enrollment target
1
Study location

Study Summary

The Chinese American Cancer Survivors Writing Study is a Randomized Controlled Trial (RCT) testing the feasibility and efficacy of the Expressive Helping (EH) intervention among Chinese American cancer survivors.

Conditions Studied

Interventions

  • BEHAVIORAL Expressive Helping
  • BEHAVIORAL Expressive Writing
  • BEHAVIORAL Factual Writing

Study Locations (1)

New York

  • New York University - New York

Trial Details

FieldValue
Enrollment Target 108 participants
Start Date 2022-07-14
Est. Completion 2026-12-31
Phase NA

Sponsor

New York University

83 total trials

What the Registry Record Tells You About NCT05456100

The ClinicalTrials.gov registry entry for NCT05456100 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 108 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 3,491-participant average among 615 other Cancer trials with a reported enrollment target (97% lower). The listed sponsor is New York University, which has 83 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Cancer appearing as the primary indexed condition, and to 3 interventions - of which Expressive Helping is the first listed.

NCT05456100 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.

Frequently Asked Questions

What is clinical trial NCT05456100 about?

NCT05456100 is a clinical study titled "Chinese American Cancer Survivors Writing Study". The Chinese American Cancer Survivors Writing Study is a Randomized Controlled Trial (RCT) testing the feasibility and efficacy of the Expressive Helping (EH) intervention among Chinese American cancer survivors.

What is the current status of trial NCT05456100?

This trial is currently recruiting. It is a NA study. The enrollment target is 108 participants. The study started on 2022-07-14. Estimated completion is 2026-12-31.

What conditions does trial NCT05456100 study?

This clinical trial studies the following conditions: Cancer.

What interventions are being tested in trial NCT05456100?

The interventions under investigation include: Expressive Helping (BEHAVIORAL), Expressive Writing (BEHAVIORAL), Factual Writing (BEHAVIORAL).

Who is sponsoring clinical trial NCT05456100?

This trial is sponsored by New York University, which has 83 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05456100 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.